Juventus Seek Shareholder Backing for €250m Equity Raise

Juventus have proposed a paid-in capital increase of up to €250m, with majority shareholder Exor advancing €60m immediately against its own share of the operation, according to Football Italia.

The payment is not additional to the proposed maximum: it counts as an advance on Exor’s eventual subscription. The move strengthens the Bianconeri’s equity position while the wider fundraising process awaits shareholder approval.

Shareholders to consider board mandate in November

At the shareholders’ meeting on 3 November, the board will ask for authorisation under Article 2443 of the Italian Civil Code to raise capital in one or more tranches, up to €250m including any share premium. Juventus expect to use the mandate in whole or in part by the end of 2026, provided market conditions are favourable.

The planned issue would be offered to existing shareholders through a rights offering. Exor holds 65.4% of Juventus and has said it will subscribe pro rata, while also offering to underwrite shares not taken up by other shareholders or third parties.

Equity needs and stated priorities

Juventus say the funds would support sporting competitiveness, potential upgrades to strategic property assets-above all the Allianz Stadium-brand development and compliance with UEFA and FIGC financial parameters. The club estimates that requirements for the current and following financial years amount to roughly 45–50% of the full mandate.

Consolidated equity stood at €11.5m on 30 June 2026, down from €13.2m a year earlier. That figure follows the €97.8m capital increase completed in November 2025. Reuters separately reported that Juventus posted a €66m loss for the year ended 30 June and forecast another loss in the current financial year, with failure to qualify for this season’s Champions League among the factors.

Exor’s commitment to subscribe its portion and cover any unsubscribed shares offers substantial backing for the proposal, but does not make the full €250m raise automatic. Its final amount and timing remain subject to the shareholder mandate and market conditions; Juventus have not specified a squad-spending allocation or guaranteed a return to profit.

The club presents the operation as support for competitiveness and longer-term financial sustainability. Exor has confirmed its support, its pro-rata participation and its willingness to underwrite a shortfall, with the immediate €60m payment treated as part of its own subscription.